Based on our findings, DPP3, GLRA3, CRCP, CHRNA5, CHRNE, and CHRNB1 genes that are involved in neurotransmitter pathways were found to be downregulated in the NK cells of AML patients as well. This evidence concerns the gene CHRNB1 and acute myeloid leukemia.